Biogen Inc. (NASDAQ:BIIB) Director Robert W. Pangia sold 5,450 shares of Biogen stock in a transaction that occurred on Monday, January 9th. The stock was sold at an average price of $295.39, for a total transaction of …
Pangaea
Partner Investment Management L.P. now owns 11,828 shares of the biotechnology company's stock worth $3,703,000 after buying an additional 4,689 shares in the last quarter. (NASDAQ:BIIB) fell -0.61% in trading …
Biogen Inc
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen (NASDAQ:BIIB) today announced that it has been advised by NASDAQ that the common stock for Bioverativ, the spinoff of its global hemophilia business, begins trading …
common stock
Biogen Inc. (NASDAQ:BIIB)’s stock has been a favorite of “smart money” aka institutions, as of late. Institutions are currently holders of 88.40% of the shares. On the other hand, company insiders are holding 0.10%. Biogen …
Biogen Inc
Below is a chart showing NANO's trailing twelve month trading history, with the $25 strike highlighted in orange: Today's Most Active Call & Put Options of the S&P 500 » Biogen Inc (BIIB) saw options trading volume of …
trading volume
Biogen Inc. (NASDAQ:BIIB) traded 1.97 Million shares and was closed at $283.01 per share. The current share price indicates that stock is -15.18% away from its one year high and is moving 26.90% ahead of its one year …
NASDAQ
Biogen Inc. (NASDAQ:BIIB) will report its next earnings on 26-Jan-17 ... analysis for Biogen Inc. and for the current quarter 22 analysts have …
Biogen Inc
Disclosure: I am/we are long CELG,BIIB. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any …
CELG
I have been patiently waiting for a bull market to begin in Biogen Inc (NASDAQ:BIIB) stock. I got my hopes up after the United States presidential election results revealed that Donald Trump was the victor, and BIIB
Biogen Idec
Biogen Inc. BIIB, -1.05% said Tuesday morning that it had agreed to pay $1.25 billion in cash to license all of Forward Pharma's FWP, +0.82% intellectual property, sending Forward Pharma shares skyrocketing 52.6% in …
Forward Pharma